Jay Stout sold $122K of Immunovant stock
By AlphaYouPublished Form 4
Stout Jay S
Reporting filer
Jay Stout reported selling 3,809 shares of Immunovant, Inc. for about $122K ($32.06 a share on average). Form 4 filed Oct 9, 2026 lists 2 entries.
See the price move since this trade →
- Disclosed
- Oct 9, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Stout Jay S | 2026-10-07 | S | Sale | 2213 | 32.06 | 203,128 | 2 days | Filed terms
|
| Common Stock | Stout Jay S | 2026-10-07 | S | Sale | 1596 | 32.06 | 201,532 | 2 days | Filed terms
|
Common Stock
- Owner
- Stout Jay S
- Date
- 2026-10-07
- Code
- S
- Action
- Sale
- Quantity
- 2213
- Price
- 32.06
- Following holdings
- 203,128
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-07
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 2213
- id: F1
- transaction Price Per Share: 32.06
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 203128
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Stout Jay S
- Date
- 2026-10-07
- Code
- S
- Action
- Sale
- Quantity
- 1596
- Price
- 32.06
- Following holdings
- 201,532
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-07
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 1596
- id: F3
- transaction Price Per Share: 32.06
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 201532
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Stout Jay S: Chief Technology Officer.
- F1: On April 1, 2025, the holder was granted 76,181 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 3, 2025, of which 4,761 of these RSUs vested on October 1, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.58 - $32.30 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- F3: On April 2, 2024, the holder was granted 54,978 RSUs, as previously reported on a Form 4 filed on April 4, 2024, of which 3,437 of these RSUs vested on October 2, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
Original sources
Prepared automatically from public filing data. Report a correction.